The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The benefits of establishing a patient advocate researcher partnership on an international cancer consortium.
 
Laura Diane Porter
No Relationships to Disclose
 
John Barnes
No Relationships to Disclose
 
Carlos Hué Garcia
No Relationships to Disclose
 
Candace L. Henley
Honoraria - Exact Sciences (Inst); Freenome (Inst)
 
Anita Isler
No Relationships to Disclose
 
Lee Jones
Consulting or Advisory Role - Bayer; Evidera/PPD; Genmab
(OPTIONAL) Uncompensated Relationships - Eisai
 
Marielle Mcleod
No Relationships to Disclose
 
Barry D. Stein
Honoraria - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BMS GmbH & Co. KG (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BMS Brazil (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BMS Brazil (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)